Skip to main content

Table 4 Effect of diets on plasma lipid profiles and hepatic lipid contents in rats fed hypercholesterolemic diets and treated with doses of β-conglycinin, fenofibrate, rosuvastatin and mixtures.

From: β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats

 

Dietary groups

 

HC

HC+7S

HC+FF

HC+RO

HC+7S+FF

HC+7S+RO

Plasma (mmol/L)

      

Total cholesterol

3.88 ± 0.22

2.99 ± 0.10*

2.49 ± 0.15**

3.15 ± 0.12*

2.33 ± 0.22**

4.00 ± 0.12

HDL-C

0.45 ± 0.02

0.70 ± 0.05*

0.88 ± 0.13*

0.68 ± 0.06

0.93 ± 0.10**

0.90 ± 0.15*

non-HDL-C

3.43 ± 0.12

2.29 ± 0.10**

1.61 ± 0.06**

2.47 ± 0.14**

1.39 ± 0.12**

2.91 ± 0.22*

Triacylglycerides

0.92 ± 0.05

0.60 ± 0.04**

0.50 ± 0.02**

0.85 ± 0.07

0.49 ± 0.03**

0.70 ± 0.05*

AI*

8.09 ± 0.07

3.52 ± 0.11**

1.96 ± 0.12**

4.09 ± 0.35**

1.53 ± 0.15**

3.67 ± 0.33**

Liver (μmol/g)

      

Total cholesterol

58.43 ± 0.85

46.22 ± 0.65**

39.58 ± 0.85**

36.04 ± 2.07**

37.86 ± 0.80**

47.13 ± 2.12**

Triacylglycerides

56.97 ± 2.15

48.52 ± 2.28*

60.06 ± 1.76

41.42 ± 2.46**

47.64 ± 2.38*

46.05 ± 2.59*

  1. 1Values are means ± SEM for nine rats. *p < 0.05 and **p < 0.001 by the Bonferroni t-test multiple comparisons versus control group (HC). HC = hypercholesterolemic diet; HC+7S = HC diet + β-conglycinin 300 mg/kg/day; HC+FF = HC diet + fenofibrate 30 mg/kg/day; HC+RO = HC diet + rosuvastatin 10 mg/kg/day; HC+7S+FF = HC diet + β-conglycinin + fenofibrate, 300 and 30 mg/kg/day respectively, and HC+7S+RO = HC diet + β-conglycinin + rosuvastatin, 300 and 10 mg/kg/day respectively. * AI = atherogenic index ware calculated as proposed by Liu et al. (2006).